Daniel Stauder
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
7
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Initiates: Market Outperform | $33 | $27.46 | +20.17% | 1 | Oct 23, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Market Outperform | $77 → $100 | $96.35 | +3.79% | 3 | Aug 20, 2024 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $19.21 | - | 1 | May 7, 2024 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $33.66 | +78.25% | 2 | Nov 29, 2023 |
Artivion
Oct 23, 2024
Initiates: Market Outperform
Price Target: $33
Current: $27.46
Upside: +20.17%
LeMaitre Vascular
Aug 20, 2024
Maintains: Market Outperform
Price Target: $77 → $100
Current: $96.35
Upside: +3.79%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $19.21
Upside: -
AtriCure
Nov 29, 2023
Reiterates: Market Outperform
Price Target: $60
Current: $33.66
Upside: +78.25%